By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Ingredients A-Z > Amino acid > NAD+ (IV / Sublingual)

NAD+ (IV / Sublingual)

GMJ
Last updated: 02/06/2026 21:12
By
Prof. Giorgi Pkhakadze
Share
8 Min Read
SHARE

Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD — GMJ Editorial Board

5 min read|995 words

What is NAD+ (IV / Sublingual)?

NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme found in every living cell that plays essential roles in energy metabolism, DNA repair, and cellular aging processes. While NAD+ is naturally produced by the body from various precursors including niacin (vitamin B3), direct NAD+ supplementation through intravenous (IV) or sublingual administration has emerged as an alternative approach to boost cellular NAD+ levels.

Unlike oral NAD+ supplements, which are largely broken down in the digestive system, IV and sublingual delivery methods aim to bypass digestive degradation and deliver NAD+ more directly to the bloodstream. IV NAD+ involves direct infusion into the bloodstream, while sublingual forms are placed under the tongue for absorption through the oral mucosa.

Health benefits & uses

Limited evidence: Most research on NAD+ has focused on precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) rather than direct NAD+ administration. Studies suggest potential benefits for:

Submit Your Paper
GMJ_Submit_Banner
  • Cellular energy production: NAD+ is essential for mitochondrial function and ATP synthesis
  • DNA repair: Required for proper function of DNA repair enzymes
  • Aging-related decline: NAD+ levels naturally decrease with age, and restoration may support healthy aging
  • Neurological function: May support brain health and cognitive function
  • Metabolic health: Involved in glucose and fat metabolism regulation

However, clinical evidence specifically for IV or sublingual NAD+ administration remains limited, with most studies conducted in laboratory or animal models. Human clinical trials are needed to establish definitive therapeutic benefits.

How it works

NAD+ functions as a coenzyme in hundreds of metabolic reactions throughout the body. It exists in two forms: NAD+ (oxidized) and NADH (reduced), which can convert between each other during cellular processes. Key mechanisms include:

Energy metabolism: NAD+ is essential for glycolysis, the citric acid cycle, and electron transport chain, helping convert nutrients into cellular energy (ATP).

DNA repair: NAD+ serves as a substrate for poly(ADP-ribose) polymerases (PARPs), enzymes that detect and repair DNA damage.

Sirtuin activation: NAD+ is required for sirtuin proteins, which regulate gene expression, DNA repair, and cellular stress responses linked to longevity.

IV and sublingual delivery methods theoretically bypass the digestive system where NAD+ would be broken down, potentially allowing higher bioavailability compared to oral supplementation.

Dosage

There are no established recommended daily allowances (RDA) or upper limits (UL) for direct NAD+ supplementation, as it is not recognized as an essential nutrient requiring external supplementation under normal circumstances.

IV NAD+: Practitioners typically use doses ranging from 250-1000mg per session, administered over several hours. Treatment frequency varies from weekly to monthly protocols.

Sublingual NAD+: Products commonly contain 25-125mg per dose, taken 1-2 times daily.

Important: NAD+ therapy should only be administered under qualified medical supervision. Dosing protocols vary significantly between providers and lack standardization due to limited clinical research.

Food sources

Direct NAD+ is not available from food sources, but the body can synthesize NAD+ from several precursors found in foods:

  • Niacin (vitamin B3): Fish, meat, poultry, enriched grains
  • Tryptophan: Turkey, milk, eggs, fish
  • Nicotinamide riboside: Milk, fish, mushrooms (in small amounts)

A balanced diet typically provides adequate precursors for normal NAD+ synthesis in healthy individuals.

Safety & side effects

Safety data for IV and sublingual NAD+ administration is limited due to lack of extensive clinical trials. Reported side effects include:

IV NAD+: Nausea, cramping, anxiety, chest tightness, and injection site reactions. Some individuals report flu-like symptoms during or after infusion.

Sublingual NAD+: Generally better tolerated, with occasional reports of mild nausea or digestive upset.

Long-term safety data is not available. The rapid increase in NAD+ levels achieved through these delivery methods may have unknown physiological consequences.

Interactions

Potential interactions with NAD+ supplementation are not well-established but theoretical concerns include:

Chemotherapy drugs: NAD+ supports DNA repair mechanisms, which could potentially interfere with cancer treatments designed to damage cancer cell DNA.

Blood pressure medications: NAD+ may influence cardiovascular function, potentially affecting blood pressure regulation.

Diabetes medications: NAD+ plays roles in glucose metabolism and could theoretically affect blood sugar control.

Consultation with healthcare providers is essential before beginning NAD+ therapy, especially for individuals taking medications or with existing health conditions.

Who should be cautious

Certain groups should exercise particular caution or avoid NAD+ supplementation:

  • Cancer patients: Enhanced DNA repair could potentially protect cancer cells
  • Pregnant or breastfeeding women: Safety data is lacking
  • Individuals with cardiovascular conditions: Due to potential effects on heart function
  • Those with autoimmune conditions: NAD+ may influence immune system function
  • Children and adolescents: No safety data available for developing individuals

Frequently asked questions

Is NAD+ supplementation better than taking precursors like NR or NMN?

This remains unclear. While direct NAD+ administration bypasses conversion steps, NAD+ precursors may be more efficiently utilized by cells and have better safety profiles. More research is needed to compare effectiveness.

How quickly do effects appear with IV NAD+ therapy?

Some individuals report feeling effects during or immediately after IV infusion, including increased energy or mental clarity. However, sustained benefits and optimal treatment protocols are not well-established.

Can I take oral NAD+ supplements instead?

Oral NAD+ supplements are generally considered less effective because NAD+ is broken down in the digestive system. NAD+ precursors like nicotinamide riboside may be more suitable for oral supplementation.

Is NAD+ therapy covered by insurance?

NAD+ therapy is typically considered experimental and is rarely covered by insurance. It’s usually offered as an elective wellness treatment at specialized clinics.

How often should NAD+ therapy be administered?

Treatment frequency varies widely among providers, from weekly to monthly sessions. There are no established protocols, and frequency should be determined by qualified healthcare providers based on individual circumstances.

Classification:

Typical dose: — · Studied up to: —

References

Authoritative profile & live regulatory status: NAD+ (IV / Sublingual) on SupplementIndex →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
How Coffee and Tea Reduce Iron Absorption: A Mechanism Explained

Polyphenols in coffee and tea bind non-heme iron in the gut, reducing…

Eggs and Alzheimer’s risk: New evidence from a 15-year study challenges decades of dietary caution

A 15-year study of 39,498 older adults found that eating eggs five…

Sleep loss triggers simultaneous damage across seven body systems, new evidence shows

Controlled studies show that restricting sleep to 4–6 hours per night for…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Betaine HCl

By
Prof. Giorgi Pkhakadze
02/06/2026

D-Aspartic Acid

By
Prof. Giorgi Pkhakadze
02/06/2026

BCAAs

By
Prof. Giorgi Pkhakadze
02/06/2026

L-Carnitine

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up